Shopping Cart 0
Cart Subtotal
USD 0

Global Cancer Treatment Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 3480

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5220

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 6960
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

Scope of the Report:

This report focuses on the Cancer Treatment Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The classification of cancer treatment drugs includes chemotherapy, targeted therapy, immunotherapy, hormonal therapy and others, and the revenue proportion of chemotherapy in 2016 is about 51%.

Cancer treatment drugs are widely used for blood cancer, breast cancer, gastrointestinal cancer, prostate cancer, respiratory/lung cancer and other cancers. Amongst these different cancer types, blood cancer was the largest revenue generating segment in 2016, and the revenue market share is about 22%. The growth of blood cancer segment is majorly due to the high cost of the drugs used to treat blood cancer.

Europe region is the largest supplier of cancer treatment drugs, with a revenue market share nearly 47% in 2016. North America is the second largest supplier of cancer treatment drugs, enjoying revenue market share nearly 34% in 2016. Japan region is also holding the monopoly position around the world.

North America is the largest consumption place, with the consumption market share nearly 43% in 2016, and North America market size reached 46 billion USD. China, India and Southeast Asia are the emerging markets, and enjoy higher grow rate.

The worldwide market for Cancer Treatment Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2023, from xx million USD in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Roche

Novartis

Celgene

Bristol-Myers Squibb

Amgen

Johnson & Johnson

Pfizer

Takeda

Eli Lilly

AstraZeneca

Astellas

Merck & Co.

Sanofi

Bayer

Biogen Idec

Eisai

Teva

Otsuka

Merck KGaA

Ipsen

AbbVie

Gilead Sciences

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Chemotherapy

Targeted Therapy

Immunotherapy

Hormonal Therapy (Biologic Therapy)

Others

Market Segment by Applications, can be divided into

Blood Cancer

Breast Cancer

Gastrointestinal Cancer

Prostate Cancer

Respiratory/Lung Cancer

Other Cancers

There are 15 Chapters to deeply display the global Cancer Treatment Drugs market.

Chapter 1, to describe Cancer Treatment Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Cancer Treatment Drugs, with sales, revenue, and price of Cancer Treatment Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Cancer Treatment Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Cancer Treatment Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Cancer Treatment Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

READ MORE

Table Of Content

Scope

Table of Contents

1 Market Overview

1.1 Cancer Treatment Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Chemotherapy

1.2.2 Targeted Therapy

1.2.3 Immunotherapy

1.2.4 Hormonal Therapy (Biologic Therapy)

1.2.5 Others

1.3 Market Analysis by Applications

1.3.1 Blood Cancer

1.3.2 Breast Cancer

1.3.3 Gastrointestinal Cancer

1.3.4 Prostate Cancer

1.3.5 Respiratory/Lung Cancer

1.3.6 Other Cancers

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Roche

2.1.1 Business Overview

2.1.2 Cancer Treatment Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Novartis

2.2.1 Business Overview

2.2.2 Cancer Treatment Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Celgene

2.3.1 Business Overview

2.3.2 Cancer Treatment Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Bristol-Myers Squibb

2.4.1 Business Overview

2.4.2 Cancer Treatment Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Amgen

2.5.1 Business Overview

2.5.2 Cancer Treatment Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Johnson & Johnson

2.6.1 Business Overview

2.6.2 Cancer Treatment Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Pfizer

2.7.1 Business Overview

2.7.2 Cancer Treatment Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Takeda

2.8.1 Business Overview

2.8.2 Cancer Treatment Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Eli Lilly

2.9.1 Business Overview

2.9.2 Cancer Treatment Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 AstraZeneca

2.10.1 Business Overview

2.10.2 Cancer Treatment Drugs Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Astellas

2.11.1 Business Overview

2.11.2 Cancer Treatment Drugs Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Merck & Co.

2.12.1 Business Overview

2.12.2 Cancer Treatment Drugs Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.13 Sanofi

2.13.1 Business Overview

2.13.2 Cancer Treatment Drugs Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.14 Bayer

2.14.1 Business Overview

2.14.2 Cancer Treatment Drugs Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.15 Biogen Idec

2.15.1 Business Overview

2.15.2 Cancer Treatment Drugs Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.16 Eisai

2.16.1 Business Overview

2.16.2 Cancer Treatment Drugs Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.17 Teva

2.17.1 Business Overview

2.17.2 Cancer Treatment Drugs Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.18 Otsuka

2.18.1 Business Overview

2.18.2 Cancer Treatment Drugs Type and Applications

2.18.2.1 Product A

2.18.2.2 Product B

2.18.3 Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.19 Merck KGaA

2.19.1 Business Overview

2.19.2 Cancer Treatment Drugs Type and Applications

2.19.2.1 Product A

2.19.2.2 Product B

2.19.3 Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.20 Ipsen

2.20.1 Business Overview

2.20.2 Cancer Treatment Drugs Type and Applications

2.20.2.1 Product A

2.20.2.2 Product B

2.20.3 Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.21 AbbVie

2.21.1 Business Overview

2.2.2 Cancer Treatment Drugs Type and Applications

2.21.2.1 Product A

2.21.2.2 Product B

2.21.3 AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.22 Gilead Sciences

2.22.1 Business Overview

2.22.2 Cancer Treatment Drugs Type and Applications

2.22.2.1 Product A

2.22.2.2 Product B

2.22.3 Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Cancer Treatment Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Cancer Treatment Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Cancer Treatment Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Cancer Treatment Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Cancer Treatment Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Cancer Treatment Drugs Market Analysis by Regions

4.1 Global Cancer Treatment Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Cancer Treatment Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Cancer Treatment Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

4.5 South America Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

5 North America Cancer Treatment Drugs by Countries

5.1 North America Cancer Treatment Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

6 Europe Cancer Treatment Drugs by Countries

6.1 Europe Cancer Treatment Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

6.3 UK Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

6.4 France Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Cancer Treatment Drugs by Countries

7.1 Asia-Pacific Cancer Treatment Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

7.5 India Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

8 South America Cancer Treatment Drugs by Countries

8.1 South America Cancer Treatment Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Cancer Treatment Drugs by Countries

9.1 Middle East and Africa Cancer Treatment Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Cancer Treatment Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Cancer Treatment Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

10 Global Cancer Treatment Drugs Market Segment by Type

10.1 Global Cancer Treatment Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Cancer Treatment Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Cancer Treatment Drugs Revenue and Market Share by Type (2013-2018)

10.2 Chemotherapy Sales Growth and Price

10.2.1 Global Chemotherapy Sales Growth (2013-2018)

10.2.2 Global Chemotherapy Price (2013-2018)

10.3 Targeted Therapy Sales Growth and Price

10.3.1 Global Targeted Therapy Sales Growth (2013-2018)

10.3.2 Global Targeted Therapy Price (2013-2018)

10.4 Immunotherapy Sales Growth and Price

10.4.1 Global Immunotherapy Sales Growth (2013-2018)

10.4.2 Global Immunotherapy Price (2013-2018)

10.5 Hormonal Therapy (Biologic Therapy) Sales Growth and Price

10.5.1 Global Hormonal Therapy (Biologic Therapy) Sales Growth (2013-2018)

10.5.2 Global Hormonal Therapy (Biologic Therapy) Price (2013-2018)

10.6 Others Sales Growth and Price

10.6.1 Global Others Sales Growth (2013-2018)

10.6.2 Global Others Price (2013-2018)

11 Global Cancer Treatment Drugs Market Segment by Application

11.1 Global Cancer Treatment Drugs Sales Market Share by Application (2013-2018)

11.2 Blood Cancer Sales Growth (2013-2018)

11.3 Breast Cancer Sales Growth (2013-2018)

11.4 Gastrointestinal Cancer Sales Growth (2013-2018)

11.5 Prostate Cancer Sales Growth (2013-2018)

11.6 Respiratory/Lung Cancer Sales Growth (2013-2018)

11.7 Other Cancers Sales Growth (2013-2018)

12 Cancer Treatment Drugs Market Forecast (2018-2023)

12.1 Global Cancer Treatment Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Cancer Treatment Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Cancer Treatment Drugs Market Forecast (2018-2023)

12.2.2 Europe Cancer Treatment Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Cancer Treatment Drugs Market Forecast (2018-2023)

12.2.4 South America Cancer Treatment Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Cancer Treatment Drugs Market Forecast (2018-2023)

12.3 Cancer Treatment Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Cancer Treatment Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Cancer Treatment Drugs Market Share Forecast by Type (2018-2023)

12.4 Cancer Treatment Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Cancer Treatment Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Cancer Treatment Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Cancer Treatment Drugs Picture

Table Product Specifications of Cancer Treatment Drugs

Figure Global Sales Market Share of Cancer Treatment Drugs by Types in 2017

Table Cancer Treatment Drugs Types for Major Manufacturers

Figure Chemotherapy Picture

Figure Targeted Therapy Picture

Figure Immunotherapy Picture

Figure Hormonal Therapy (Biologic Therapy) Picture

Figure Others Picture

Figure Cancer Treatment Drugs Sales Market Share by Applications in 2017

Figure Blood Cancer Picture

Figure Breast Cancer Picture

Figure Gastrointestinal Cancer Picture

Figure Prostate Cancer Picture

Figure Respiratory/Lung Cancer Picture

Figure Other Cancers Picture

Figure United States Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure France Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure UK Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure China Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure India Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Cancer Treatment Drugs Revenue (Value) and Growth Rate (2013-2023)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Cancer Treatment Drugs Type and Applications

Table Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Cancer Treatment Drugs Type and Applications

Table Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Celgene Basic Information, Manufacturing Base and Competitors

Table Celgene Cancer Treatment Drugs Type and Applications

Table Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors

Table Bristol-Myers Squibb Cancer Treatment Drugs Type and Applications

Table Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Amgen Basic Information, Manufacturing Base and Competitors

Table Amgen Cancer Treatment Drugs Type and Applications

Table Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Cancer Treatment Drugs Type and Applications

Table Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Cancer Treatment Drugs Type and Applications

Table Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Takeda Basic Information, Manufacturing Base and Competitors

Table Takeda Cancer Treatment Drugs Type and Applications

Table Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Eli Lilly Basic Information, Manufacturing Base and Competitors

Table Eli Lilly Cancer Treatment Drugs Type and Applications

Table Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table AstraZeneca Basic Information, Manufacturing Base and Competitors

Table AstraZeneca Cancer Treatment Drugs Type and Applications

Table AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Astellas Basic Information, Manufacturing Base and Competitors

Table Astellas Cancer Treatment Drugs Type and Applications

Table Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Merck & Co. Basic Information, Manufacturing Base and Competitors

Table Merck & Co. Cancer Treatment Drugs Type and Applications

Table Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Basic Information, Manufacturing Base and Competitors

Table Sanofi Cancer Treatment Drugs Type and Applications

Table Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Bayer Basic Information, Manufacturing Base and Competitors

Table Bayer Cancer Treatment Drugs Type and Applications

Table Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Biogen Idec Basic Information, Manufacturing Base and Competitors

Table Biogen Idec Cancer Treatment Drugs Type and Applications

Table Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Eisai Basic Information, Manufacturing Base and Competitors

Table Eisai Cancer Treatment Drugs Type and Applications

Table Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Teva Basic Information, Manufacturing Base and Competitors

Table Teva Cancer Treatment Drugs Type and Applications

Table Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Otsuka Basic Information, Manufacturing Base and Competitors

Table Otsuka Cancer Treatment Drugs Type and Applications

Table Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Merck KGaA Basic Information, Manufacturing Base and Competitors

Table Merck KGaA Cancer Treatment Drugs Type and Applications

Table Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Ipsen Basic Information, Manufacturing Base and Competitors

Table Ipsen Cancer Treatment Drugs Type and Applications

Table Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table AbbVie Basic Information, Manufacturing Base and Competitors

Table AbbVie Cancer Treatment Drugs Type and Applications

Table AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Gilead Sciences Basic Information, Manufacturing Base and Competitors

Table Gilead Sciences Cancer Treatment Drugs Type and Applications

Table Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Cancer Treatment Drugs Sales by Manufacturer (2016-2017)

Figure Global Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016

Figure Global Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017

Table Global Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)

Figure Global Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016

Figure Global Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017

Figure Top 3 Cancer Treatment Drugs Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Cancer Treatment Drugs Manufacturer (Revenue) Market Share in 2017

Figure Global Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure Global Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)

Table Global Cancer Treatment Drugs Sales by Regions (2013-2018)

Table Global Cancer Treatment Drugs Sales Market Share by Regions (2013-2018)

Table Global Cancer Treatment Drugs Revenue by Regions (2013-2018)

Figure Global Cancer Treatment Drugs Revenue Market Share by Regions in 2013

Figure Global Cancer Treatment Drugs Revenue Market Share by Regions in 2017

Figure North America Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure Europe Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure South America Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure North America Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)

Table North America Cancer Treatment Drugs Sales by Countries (2013-2018)

Table North America Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)

Figure North America Cancer Treatment Drugs Sales Market Share by Countries in 2013

Figure North America Cancer Treatment Drugs Sales Market Share by Countries in 2017

Table North America Cancer Treatment Drugs Revenue by Countries (2013-2018)

Table North America Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)

Figure North America Cancer Treatment Drugs Revenue Market Share by Countries in 2013

Figure North America Cancer Treatment Drugs Revenue Market Share by Countries in 2017

Figure United States Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure Canada Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure Mexico Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure Europe Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)

Table Europe Cancer Treatment Drugs Sales by Countries (2013-2018)

Table Europe Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)

Table Europe Cancer Treatment Drugs Revenue by Countries (2013-2018)

Figure Europe Cancer Treatment Drugs Revenue Market Share by Countries in 2016

Figure Europe Cancer Treatment Drugs Revenue Market Share by Countries in 2017

Figure Germany Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure UK Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure France Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure Russia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure Italy Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Cancer Treatment Drugs Sales by Countries (2013-2018)

Table Asia-Pacific Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Cancer Treatment Drugs Sales Market Share by Countries 2017

Table Asia-Pacific Cancer Treatment Drugs Revenue by Countries (2013-2018)

Figure Asia-Pacific Cancer Treatment Drugs Revenue Market Share by Countries 2017

Figure China Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure Japan Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure Korea Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure India Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure Southeast Asia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure South America Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)

Table South America Cancer Treatment Drugs Sales by Countries (2013-2018)

Table South America Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)

Figure South America Cancer Treatment Drugs Sales Market Share by Countries in 2017

Table South America Cancer Treatment Drugs Revenue by Countries (2013-2018)

Table South America Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)

Figure South America Cancer Treatment Drugs Revenue Market Share by Countries in 2017

Figure Brazil Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure Argentina Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure Colombia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Cancer Treatment Drugs Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Cancer Treatment Drugs Sales by Countries (2013-2018)

Table Middle East and Africa Cancer Treatment Drugs Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Cancer Treatment Drugs Sales Market Share by Countries in 2017

Table Middle East and Africa Cancer Treatment Drugs Revenue by Countries (2013-2018)

Table Middle East and Africa Cancer Treatment Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Cancer Treatment Drugs Revenue Market Share by Countries in 2013

Figure Middle East and Africa Cancer Treatment Drugs Revenue Market Share by Countries in 2017

Figure Saudi Arabia Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure UAE Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure Egypt Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure Nigeria Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Figure South Africa Cancer Treatment Drugs Sales and Growth Rate (2013-2018)

Table Global Cancer Treatment Drugs Sales by Type (2013-2018)

Table Global Cancer Treatment Drugs Sales Share by Type (2013-2018)

Table Global Cancer Treatment Drugs Revenue by Type (2013-2018)

Table Global Cancer Treatment Drugs Revenue Share by Type (2013-2018)

Figure Global Chemotherapy Sales Growth (2013-2018)

Figure Global Chemotherapy Price (2013-2018)

Figure Global Targeted Therapy Sales Growth (2013-2018)

Figure Global Targeted Therapy Price (2013-2018)

Figure Global Immunotherapy Sales Growth (2013-2018)

Figure Global Immunotherapy Price (2013-2018)

Figure Global Hormonal Therapy (Biologic Therapy) Sales Growth (2013-2018)

Figure Global Hormonal Therapy (Biologic Therapy) Price (2013-2018)

Figure Global Others Sales Growth (2013-2018)

Figure Global Others Price (2013-2018)

Table Global Cancer Treatment Drugs Sales by Application (2013-2018)

Table Global Cancer Treatment Drugs Sales Share by Application (2013-2018)

Figure Global Breast Cancer Sales Growth (2013-2018)

Figure Global Gastrointestinal Cancer Sales Growth (2013-2018)

Figure Global Prostate Cancer Sales Growth (2013-2018)

Figure Global Respiratory/Lung Cancer Sales Growth (2013-2018)

Figure Global Other Cancers Sales Growth (2013-2018)

Figure Global Cancer Treatment Drugs Sales, Revenue and Growth Rate (2018-2023)

Table Global Cancer Treatment Drugs Sales Forecast by Regions (2018-2023)

Table Global Cancer Treatment Drugs Market Share Forecast by Regions (2018-2023)

Figure North America Sales Cancer Treatment Drugs Market Forecast (2018-2023)

Figure Europe Sales Cancer Treatment Drugs Market Forecast (2018-2023)

Figure Asia-Pacific Sales Cancer Treatment Drugs Market Forecast (2018-2023)

Figure South America Sales Cancer Treatment Drugs Market Forecast (2018-2023)

Figure Middle East and Africa Sales Cancer Treatment Drugs Market Forecast (2018-2023)

Table Global Cancer Treatment Drugs Sales Forecast by Type (2018-2023)

Table Global Cancer Treatment Drugs Market Share Forecast by Type (2018-2023)

Table Global Cancer Treatment Drugs Sales Forecast by Application (2018-2023)

Table Global Cancer Treatment Drugs Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Roche

Novartis

Celgene

Bristol-Myers Squibb

Amgen

Johnson & Johnson

Pfizer

Takeda

Eli Lilly

AstraZeneca

Astellas

Merck & Co.

Sanofi

Bayer

Biogen Idec

Eisai

Teva

Otsuka

Merck KGaA

Ipsen

AbbVie

Gilead Sciences